3 Of The Best Marijuana Stocks To Buy For Possible Gains In 2026
The big question for marijuana stock investors is how the market will react to the newly passed bill to reverse the 2018 Farm Bill. A new bill was recently passed with language that essentially overturned the Hemp laws in the USA. Many legal operators produced hemp and CBD products to ensure compliance under the bill as a way to energetically take part in the industry. Now, legal operators in legal states cultivating cannabis vs hemp have an entirely different legal road map to follow. Yet this is what many are calling a step backwards, and rightfully so.
Aurora Cannabis Inc. (ACB) Tops Q2 Earnings and Revenue Estimates
Aurora Cannabis Inc. (ACB) came out with quarterly earnings of $0.09 per share, beating the Zacks Consensus Estimate of $0.03 per share. This compares to earnings of $0.04 per share a year ago.
'Trump effect' raises hopes for cannabis rally as investors bet on federal reforms, softer marijuana stance
Cannabis stocks could rally on hopes for new hemp regulations and Trump's possible softer stance on marijuana, fueling investor optimism across the industry.
Pot Stocks Plunge After Rally: Is Betting on Rescheduling Worth the Risk?
Key Points in This Article: Cannabis stocks surged in 2018-2019 on federal legalization hopes but crashed as progress stalled.
Top Canadian Marijuana Stocks If Federal Reform Passes In The USA
Marijuana stocks have begun to gain traction in trading, exhibiting moderate consistency. But why did this occur, and what is happening to bring such momentum to the sector? Once again, the backing and favorable side of passing federal reform for cannabis is being discussed by top politicians. In recent talks, President Donald Trump voiced his stance on cannabis and how it should be legalized under the right conditions.
ACB Stock Down as Q1 Earnings Miss Estimates, Revenues Up Y/Y
Aurora Cannabis stock slips after Q1 earnings miss, but revenue climbs 17.5% year over year on strong global medical cannabis demand.
Aurora Cannabis Inc. (ACB) Reports Q1 Loss, Beats Revenue Estimates
Aurora Cannabis Inc. (ACB) came out with a quarterly loss of $0.19 per share versus the Zacks Consensus Estimate of $0.18. This compares to a loss of $0.11 per share a year ago.
Here Is A Way Marijuana Stocks Can Make You A Return On Your Investment
This moment in time for marijuana stock investors could be the best opportunity. Legal cannabis is a volatile sector where MSO and ancillary companies are dominating it. Even with a drop in value for the sector, gains are still being made by these companies. What this does is signal that even if the public sector is seeing all-time lows in money, progress is being made.
3 Top Canadian Marijuana Stocks To Watch As The Sector Looks To Bounce
2025 has been a troubled time for marijuana stock investors. With a lack of momentum and no sign of any upward trading, what are shareholders to do? Now, the cannabis industry outside of the public sector has been doing phenomenally. Some cannabis companies continue to grow and become even bigger and profitable. At this time, the legal market still faces an uphill climb, but as long as companies can fulfill the increase in consumer demand there is a light at the end of the tunnel.
Aurora Cannabis Inc. (ACB) Announces Filing and Mailing of the Management Information
Aurora Cannabis Inc. (the “Company” or “Aurora”) (NASDAQ: ACB) (TSX: ACB), a leading Canada-based global medical cannabis company, is pleased to announce that the management information circular (the “Circular”) for the upcoming annual general and special meeting of shareholders is now available on the Company's website at www.auroramj.com/investors/corporate-governance as well as under its profile on SEDAR+ (www.sedarplus.ca). The mailing of the Circular and related materials for the Meeting to shareholders as of the record date on June 16, 2025, has been completed.
Aurora Cannabis Inc. (ACB) Q4 2025 Earnings Call Transcript
Aurora Cannabis Inc. (NASDAQ:ACB ) Q4 2025 Earnings Conference Call June 18, 2025 8:00 AM ET Company Participants Kevin Niland - Corporate Participant Miguel Martin - CEO & Executive Chairman Simona King - Chief Financial Officer Conference Call Participants Derek J. Lessard - TD Cowen, Research Division Frederico Yokota Choucair Gomes - ATB Capital Markets Inc., Research Division Matt Bottomley - Canaccord Genuity Corp., Research Division Pablo Ernesto Zuanic - Zuanic & Associates William Joseph Kirk - ROTH Capital Partners, LLC, Research Division Operator Greetings.
Aurora Cannabis Inc. (ACB) Misses Q4 Earnings Estimates
Aurora Cannabis Inc. (ACB) came out with quarterly earnings of $0.07 per share, missing the Zacks Consensus Estimate of $0.11 per share. This compares to earnings of $0.11 per share a year ago.
